Siberian vaccine is dry dry for subcutaneous and scarification applications. As a person reacts to vaccines from Siberian ulcers as the introduction of vaccine

Siberia vaccine

Instructions for the use of a vaccine of a symbolic alive dry for subcutaneous and scarification applications

The vaccine is the living spores of the vaccine siberiane strain, lyophilized in a 10% aqueous sucrose solution, has the form of a homogeneous porous mass of grayish-white or yellowish-bes.

Immunological properties

Siberian vaccine vaccine is dry after twofold use with an interval of 20 ... 30 days causes the formation of intense immunity to 1 year.

Purpose

Specific prevention of Siberian ulcers since the age of 14 years.

Grafs are subject to:
• persons working with alive cultures of the pathogen of Siberian ulcers, with infected laboratory animals or producing studies of materials infected with the pathogen of Siberian ulcers;
• persons who produce slaughter of livestock engaged in the preparation, collection, storage, transportation, processing and sale of raw materials of animal origin;
• persons performing the following work on enzootic in the Siberian ulcers of territories:
  - service of social livestock;
  -Excorce, agro- and hydroelectric, construction and other works associated with the extraction and movement of the soil;
  - Preparation, commercial, geological, express, expeditionary.

In a planned procedure, vaccination is carried out by the crossing method in the first quarter of the year, since the Siberian Siberian Siberian Season is the most dangerous in relation to infection of the Siberian ulcer.

Method of application and dosage

The vaccine is used by the civory (scanning) and subcutaneous methods. An unscheduled vaccination of the price is forestly to conduct a subcutaneous way.

Primary immunization is carried out twice with an interval of 20 ... 30 days, revaccination is carried out annually once. For all vaccinations on the skin dose, the vaccine is 0.05 ml and contains 500 million disputes, one under the skin dose of 0.5 ml - 50 million dispute.

Before use, every ampoule with vaccine is carefully promoted. It is not subject to vaccine: if the integrity of the ampoule is damaged, the change in the appearance of dry and dissolved drug (extraneous particles, undersified lumps and flakes), the absence of a label, after the expiration date, disorders of the storage mode.

Cavation vaccination (scarification)

The contents of the ampoule immediately before use are resuspended in a sterile 30% aqueous glycerin solution, which is made in an ampoule with a syringe with a needle for intramuscular administration. The volume of the solvent is determined by the amount of vaccination doses in the ampoule. In an ampoule with 10 cables, 0.5 ml is made, and with 20 cabled doses - 1.0 ml of solvent. The ampoule shakes up to the formation of a homogeneous suspension. The dissolution time of the vaccine should not exceed 5 minutes. The diluted vaccine from the opened ampule, stored in aseptic conditions, can be used for 4 hours. The vaccination is produced on the outer surface of the middle third of the shoulder. The vaccination place is treated with alcohol or a mixture of alcohol with ether. The use of other disinfecting solutions is not allowed. After evaporation of alcohol and ether with a sterile tuberculin syringe with a thin and short needle (No. 0415), without touching the skin, applied in one drop (0, 025 ml) of the diluted vaccine in 2 places of future notes at a distance of 3 ... 4 cm. Skin Slightly stretch and sterile spermnuctive pen through each drop of vaccine are made by 2 parallel notches with a length of 10 mm with such a calculation so that they are not bleeding (blood should only act as small residues). The flat side of the precious fever vaccine is rubbed in the notches for 30 s and give dry 5 ... 10 min. For each vaccinated, a separate disposable pen is used. It is forbidden to enjoy the needles, scalpels, etc.

Vaccination subcutaneous method

The drug immediately before applying is resuspended in 1, 0 ml of sterile 0, 9% sodium chloride solution. The ampoule shakes the formation of a uniform suspension. The contents of the ampoule sterile syringe are transferred to the sterile bottle with 0, 9% sodium chloride solution for injection. In the case of using an ampoule containing 200 subcutaneous vaccination doses, the suspension is transferred to a vial with 99 ml, and 100 subcutaneous vaccination doses containing 100 subcutaneous doses is in a vial with 49 ml of solvent.

In the syringe method, the vaccine is introduced into the lower corner area of \u200b\u200bthe dealer. The skin at the injection site is treated with alcohol or a mixture of alcohol with ether. Vaccine in volume 0, 5 ml is administered subcutaneously. For each vaccinated, a disposable syringe and needle use. Before each selection vaccine vaccine shakes. The injection site is lubricated by 5% of the iodine tincture.

When applying the vaccine subcutaneously, an spore suspension is introduced in a volume of 0, 5 ml to the outer surface area of \u200b\u200bthe versions of the shoulder with an unrelated injector with a tread with a strict compliance with the instructions for their use. The place of introduction of the vaccine before and after injection is treated, as in the syringe method.

Unused vaccine used by vaccination single-dimensional syringes and feathers are subject to mandatory inactivation by autoclaving at a temperature (132 ± 2) ° C and pressure 2, 0 kgf / m 2 for 90 minutes.

Parts of the oscillation injector, in contact with the vaccine, after pre-treatment are immersed in a 6% solution of hydrogen peroxide C 0, 5% of the "Progress" or Astra detergent or Astra at a temperature of 50 ° C. The solution is used once.

Parts of the injection are sterilized by autoclaving at a temperature (132 ± 2) ° C and pressure 2, 0 kgf / m 2 for 90 minutes.

Reaction to Introduction

With the abnormal application, the local software reaction is 24 ... 48 hours in the form of hyperemia, a small infiltration from the afterwarding formation of a yellowish crust in the course of sweeps. In the syringe of the BO and the irrelevant methods of administration after 24 ... 48 hours at the injection site, there may be small soreness, hyperemia, less often - infiltrate with a diameter of up to 50 mm.

The overall reaction in the coexuscial and subcutaneous administration of the vaccine rarely occurs in the first day after vaccination and is manifested by ailmentary, fishing pain and a minor increase in temperature. Sometimes there may be an increase in body temperature to 38, 5 ° C and a slight increase in regional lymph nodes.

Contraindications

• Acute infectious and non-infectious diseases - vaccinations are carried out no earlier than 1 month after recovery (remission).
• Primary and secondary immunodeficiency. When treating steroids, antimetabolites, vaccination radiotherapy is carried out no earlier than 6 months after the end of therapy.
• Malignant neoplasms and malignant blood diseases.
• Systemic communication tissue diseases.
• Common recurrent skin diseases.
• Diseases of the endocrine system.
• Pregnancy and lactation period.

In each case, during diseases that are not contained in the standing list, vaccination is carried out only by resolving the corresponding medical specialist.

The interval between vaccination against the Siberian ulcers and the introduction of other vaccines should be at least one month. In order to identify contraindications, the doctor (Feldsher) on the vaccination day conducts a survey and inspection of the mandatory thermometry.

Vaccination conducts medium medical personnel under the guidance of the doctor.

Form release

1, 0 ml of vaccine in an ampoule, containing 200 human co-doses for subcutaneous or 20 human-doses for the cable vaccination with 1, 5 ml of the solvent for the cable application - 30% of the aqueous solution of Gly Cerin.

According to 1, 0 ml of vaccine in an ampoule containing 100 human-doses for under the skin or 10 human-doses for the cake of vaccination with 1, 0 ml of solvent for the COV use - 30% of the aqueous glycerol solution.

Packaging contains 5 ampoules vaccine and 5 ampoules solvent

Storage and Transport Conditions

The vaccine is stored and transported in accordance with the joint venture 3. 3. 2. 028-95 at temperatures from 2 to 10 ° C. Trans porting can also be carried out at a temperature not higher than 25 ° C for no more than 20 days.

Shelf life

Vaccine produced under vacuum - 4 years; Release the keyless without vacuum - 3 years.

Dosage form: & nbsplyophilisate for the preparation of suspension for subcutaneous administration and scarification application Composition:

Siberian vaccine vaccine, lyophilisate for the preparation of suspension for subcutaneous administration and scarification application, is a lyophilized suspension of living vaccine strain dispute Bacillus AnthracisSTI-1.

Stabilizer - 10% sucrose solution.

Description: Porous mass of grayish-white or yellowish white color with a brownish tint. Pharmacotherapeutic Group:MIBP - ATX Vaccine: & NBSP

J.07.A.c. Vaccine for the prevention of Siberian ulcers

J.07.A.C.01 Siberiane antigen

Pharmacodynamics:

The vaccine is a siberiaic living after twofold use with an interval of 20-30 days causes the formation of specific immunity to 1 year.

Indications:

Specific prevention of Siberian ulcers in people from 14 years of age. Vaccination is carried out in a planned manner and by epidemic testimony.

Planned vaccinations are subject to:

Persons working with alive cultures of the pathogen of Siberian ulcers, with infected laboratory animals or producing studies of materials infected with the pathogen of Siberian ulcers;

Persons who produce slaughter of livestock engaged in the preparation, collection, storage, transportation, processing and sale of raw materials of animal origin;

Persons performing the following work on enzootic in the Siberian ulcers of territories:

Public livestock service;

Agricultural, agro- and hydro-elevative, construction and other works associated with the extraction and movement of the soil;

Procurement, commercial, geological, express, expeditionary.

In a planned order, vaccination is carried out in the first quarter of the year, because The most dangerous in relation to the infection of the Siberian ulcer in disadvantaged points is the Spring-Summer season.

Contraindications:

1. Acute infectious and non-infectious diseases - vaccinations are carried out no earlier than 1 month after recovery (remission).

2. Primary and secondary immunodeficiency. When treating steroids, antimetabolites, vaccination X-ray therapy is carried out no earlier than 6 months after the end of therapy.

3. Malignant neoplasms and malignant blood diseases.

4. Systemic connective tissue diseases.

5. Common recurrent skin diseases.

6. Diseases of the endocrine system.

7. Pregnancy and lactation period.

In each case, during diseases not contained in this list, vaccination is carried out only By permission. The appropriate specialist doctor.

In order to identify contraindications, the doctor (Feldsher) on the vaccination day conducts a survey and inspection of the mandatory thermometry.

Method of use and dose:

Vaccination conducts medium medical personnel under the guidance of the doctor.

Planned vaccination. Primary immunization is carried out by a scarification method twice with an interval of 20-30 days, revaccination - once every year in the subcutaneous method.

Vaccination by epidemic testimonyconducted by subcutaneous way. If necessary, revaccination is carried out once annually by the subcutaneous method.

Before use, each ampoule with vaccine is carefully browsing. It is not subject to vaccine to damage the integrity of the ampoule, changing the appearance of a dry and dissolved drug (the presence of extraneous inclusions, unwanted lumps and flakes), the absence of a label, expiration of the shelf life, the storage mode.

1. Vaccination of the civory (scarification) method. Based on the amount of vaccination doses, the contents of the ampoule (vial) immediately before use resuspended in a solvent - a sterile 30% aqueous glycerol solution with a syringe with a needle for intramuscular administration (No. 0840). In the ampoule (bottle) with 10 cabled doses, 0.5 ml is made, and with 20 cables - 1.0 ml of solvent and shake up to the formation of a homogeneous suspension of a grayish-white or yellowish-white color with a brownish tint. The dissolution time of the vaccine should not exceed 5 minutes. Divorced vaccine stored in aseptic conditions can be used for 4 hours.

The vaccine is produced on the outer surface of the middle third of the shoulder. The vaccination place is treated with 70% alcohol. The use of other disinfecting solutions is not allowed. After evaporation of alcohol with a sterile tuberculin syringe with a thin and short needle (No. 0415), without touching the skin, they are applied in one drop (0.025 ml) of the diluted vaccine in 2 places of future notes at a distance of 3-4 cm on the horizontally located surface of the shoulder. The skin is slightly stretched and a sterile precipitative pen through each drop of vaccine is made by 2 parallel notches (at a distance of 3-5mm) Long 10 mm with such a calculation so that they do not bleed (blood can only speak in the form of small residues). The flat side of the precious fever vaccine is rubbed in the notches for 30 s and give dry for 5-10 minutes. For each vaccinated, a separate disposable pen is used.

It is forbidden to enjoy the needles, scalpels, etc.

2. Vaccination subcutaneous method.

The drug immediately before applying is resuspended in 1 ml of sterile sodium chloride solution of 0.9%. The ampoule (bottle) shakes up to the formation of a uniform suspension of a grayish-white or yellowish-white color with a brownish tint. The contents of the ampoule (vial) sterile syringe are transferred to a sterile bottle with sodium chloride with a solution of 0.9% for injection. In the case of using an ampoule (vial) containing 200 subcutaneous vaccination doses, the suspension is transferred to a vial with 99 ml, and 100 subcutaneous vaccination doses containing 100 subcutaneous vaccine doses is in a vial with 49 ml of solvent.

With a syringe methoda vaccine in a volume of 0.5 ml is administered subcutaneously to the field of the lower corner of the blade. 70% treated skin at the injection site alcohol. Before each selection vaccine vaccine shakes. The injection site is lubricated by 5% of the iodine tincture.

With an irrelevant method A vaccine in a volume of 0.5 ml is introduced into the region of the outer surface of the upper third of the shoulder with an unrelated injector with a tread with a strict compliance with the instructions for its use. The place of introduction of the vaccine before and after injection is treated, as at the subcutaneous method.

Unused vaccine used by vaccination disposable syringes and feathers are subject to mandatory inactivation by autoclaving at a temperature of (132 ± 2) ° C and a pressure of 2.0 kgf / m 2 for 90 minutes.

Parts of the oscillation injector in contact with the vaccine are immersed in 6 % hydrogen peroxide solution with 0.5% Washing agent type "Progress" or "Astra" at 1 h at a temperature not lower than 50 ° C. The solution is used once. Then conduct preservation of the injection processing:

a) rinsing under running water for 0.5 min;

b) soaking with full immersion in the washing solution at a temperature of 50 ° C for 15 minutes. Reception of 1 l of detergent solution: 17 g Pergel (27.5 g 33% hydrogen peroxide), 5 g of detergent and 978 ml of water;

c) washing in detergent solution using a tap or a gauze tampon of each item for 0.5 min;

d) rinsing under running water for 10 minutes;

d) rinsing with distilled water for 0.5 min of each item;

e) drying to the complete disappearance of moisture.

Sterilization of parts of the oscillation injector are carried out by autoclaving at a temperature (132 ± 2) ° C and pressure2.0 kgf / m 2 for 90 minutes.

Reaction to Introduction

Vaccine vaccinations may be accompanied by local reactions, the intensity of which depends on the individual characteristics of the vaccinated. After 24-48 hours, hyperemia may occur at the injection site of the vaccine, the infiltrate, followed by the formation of a crust of yellowish color in the course of the introduction of the vaccine. After 24-48 hours after subcutaneous vaccination at the injection site, soreness may occur, hyperemia, less frequently infiltrate with a diameter of up to 50 mm.

Side effects:

It can manifest itself in the first day after grafting by ailment, headache and an increase in body temperature up to 38.5 ° C.

Interaction: Interval between VACCinacitit should be against the Siberian ulcers and the introduction of other vaccines should be at least one month, and in relation to children's contingents - at least two months.

Vaccine is sensitivetoantibiotics, in connection with which the immunization against the background of the use of antibiotics is not allowed.

Release form / Dosage:The lyophilisate for the preparation of the suspension for subcutaneous administration and the cable scarification application. Packaging:

200 subcutaneous or 20 cables in ampoule (vial) (solvent - 30% glycerol solution of 1.5 ml in ampoule) or 100 subcutaneous or 10 cableing doses in ampoule (vial) (solvent - 30% glycerol solution 1, 0 ml in ampoule).

A special vaccine is intended for introducing it to persons working with the causative agent of Siberian ulcers, those who, by virtue of the profession, deals with a livestock of various purposes. It is used as prophylaxis and helps protect against this disease. Siberian vaccine vaccine vaccine can be released both in dry and liquid form, but it is necessary to breed special means for injection.

How is the introduction of vaccine

Vaccinations against Siberian ulcers are introduced both subcutaneously and superfluously. Primary vaccination, as well as unscheduled, is done subcutaneously. Primary immunization is performed necessarily two-time with a small interval (about a month). Revaccination is certainly carried out one time per year. The capeless dose of the required vaccine in its composition contains a very large number of dispute. The contents of a similar ampoule before the introduction are bred with a sterile solution of glycerol in the required proportions.

The volume of the solvent to be used is calculated directly by the number of doses of vaccinations contained in one ampoule. The dissolution time of the fund used should not be more than 5 minutes.

The finished tool that is contained in the ampoule used can be stored only 4 hours, and then it must be recycled.

It is worth noting: Siberian vaccine vaccine can be maintained in sterile conditions, because it can very quickly lose its qualities.

Vaccination is necessarily carried out on the outer surface of the middle of the shoulder. The vaccination venue is previously treated with alcohol, because only this tool is ideal for disinfection. After completely drying the alcohol with a new syringe with a pretty small needle, without touching the skin, you need to apply one droplet of the drug on 2 places where scratches will be made (about a few millimeters). After that, the skin spots are slightly stretched, and two scratches used in a special feature, but with such a calculation, so that they are not very bleeding. Scratches must be not very deep, so blood should be bought only in the form of small droplets. A flat sterile side after that the tool is very well rubbed into the scratches performed for about 30 seconds, and then give it to completely dry.

For each person, a special feather is used. It is strictly forbidden to use instead of feathers of various kinds of scalpels, a variety of needles and other substitutes.

Back to the category

Indications for vaccination and administration methods

The prevention of Siberian ulcers is carried out by persons over 14 years old. The mandatory vaccination is subject to:

• people who work with alive or weakened cultures of the most Siberian ulcers;
• people who spend slaughter cattle;
• people who spend the required service of cattle;
• workers who are engaged in the recess and subsequent movement of the soil;
• people whose work is associated with expeditions.

In a planned procedure, the required vaccination is carried out by the assault way, mainly in the first quarter of each year, because the most dangerous in the plan of infection is precisely the spring-summer period.

Vaccination can be carried out both subcutaneous and superficial method. For the subcutaneous application of the application of vaccinations, it is strictly forbidden to take a vaccine that has been diluted pre-for the assault rod. The means used for the subcutaneous method is dissolved in 1 ml of sodium chloride. Then ampoule is thoroughly shaken to obtain a high-quality homogeneous suspension. The contents of the ampoule are neatly transferred to the injection means.

In the syringe method, the tool is introduced directly to the region of the lower portion of the blade. Skin covers at the place of administration of the required injection are pre-treated with alcohol. For vaccination, you need to use 0.5 ml of the vaccine, which is introduced subcutaneously. For each seizable, disposable sterile syringe and needle are used. Before each fence, the bottle is thoroughly shaken. The injection location after that is processed by iodine.

When using a vaccine, a dilute spore injection is administered in a volume of 0.5 ml into the middle area of \u200b\u200bthe shoulder, and the non-free injector with a special tread is used, and the instructions are used strictly. The place of direct introduction of such a vaccine before and after vaccination is carefully processed.

The vaccine is a symbiotic fluid dry, as well as the applied tools and means for its introduction are to be destroyed at very high temperatures in special devices.

Parts of the exhausted injector used, which come into contact with the means themselves are immersed in a special disinfection solution.

It contains live spores of the vaccine strain STI-1, lyophilic dried in a 10% solution of sucrose. Named in honor of the Sanitary Institute, where it was developed. For the manufacture of vaccine, a resistant variant (mutant) of antiquated bacteria, devoid of capsules and ability to cause diseases in people and animals, is used to prevent Siberian ulcers for epidemiological indications in people aged 14 to 60 years. Vaccination is carried out twice with an interval of 21 days, revaccination - annually, once. Vaccination is carried out by persons engaged in the collection, storage, transportation and processing of raw materials of animal origin, as well as staff engaged in the cloth, cutting out the carcass and removal of the skins. The drug is injected from or subcutaneously.

Siberian combined liquid vaccine for subcutaneous use.

The drug is a mixture of the living spore of the vaccine strain of the Siberian Siberian microbe and a purified, concentrated, adsorbed on the hydroxide of the aluminum of the Protective Siberian Antigen (PA). Vaccine is used to prevent Siberian ulcers from people from 14 to 60 years. Vaccination is carried out once, the first three revaccinations are carried out at intervals of 1 year, the following three - with an interval of 2 years. Stressful immunity is formed in 7 days after the first introduction of the vaccine: and persists during the year. The drug is administered subcutaneously.

Glaubinulin anti-cycling horsepower liquid.

Contains antibodies against the causative agent of Siberian ulcers. Upon receipt of the preparation of horses is hyperimmunomized, then from the serum by the method of precipitation with ethanol at low temperatures, the fractions of gamma and beta globulins are distinguished. Preservatives does not contain. Used for emergency prevention and treatment of patients with Siberian ulcers. The drug is injected intramuscularly. The preventive purpose is introduced once (in possibly shorter time after a suspected infection), with therapeutic - immediately after the diagnosis of Siberian ulcers for 3 to 4 days. Before using the drug, it is necessary to carry out intradermal sample. With a positive sample, globulin is administered only on life testimony under the supervision of the doctor.

Preparations for the prevention and treatment of staphylococcal infection

Anatoksin staphylococcal cleaned adsorbing.

Contains 1 ml of 10 EU staphylococcal anatoxine. In the manufacture of the preparation staphylococcal toxin (contained in the filtrate of the staphylococcus broth) is neutralized with formalin and heat, precipitated with trichloroacetic acid, purified by ethyl alcohol and adsorbed on aluminum hydroxide. With the introduction of ansis in the body, it induces the formation of antitoxic antibodies. Used to prevent staphylococcal infections. The drug is introduced:

a) working, exposed to high risk of injury: b) patients who are coming by planned operations: c) pregnant women: d) donors in order to obtain anti-staphylococcal plasma and antistaphococcal immunoglobulin. Anatoksin is administered subcutaneously, usually twice with an interval of 20 - 40 days.

Vaccine staphylococcus.

It contains the suspension of staphylococci at a 0.9% solution of ACI, inactivated by heating for 2 hours at 560 C. The vaccine is prepared from 10 to 12 coagulazoral stamps of staphylococcus selected from patients. Preservative - phenol. The drug is used to treat adults in various diseases of staphylococcal and streptostostococcal etiology: recurrent furunculosis, pyodermium, panaria, drain acne, etc. The vaccine is injected subcutaneously or intramuscularly.

Vaccine stafilo-protein-cinema adsorbed liquid.

It is a complex of purified, concentrated anteoxins of staphylococcal and a cinema stick, the cytoplasmic antigen of staphylococcal and the chemical protein vaccine adsorbed on aluminum hydroxide. The drug is used to active immunization of patients aged 18 - 60 years in order to prevent infections caused by staphylococci, proteate and a cinema stick. The vaccine should be administered to patients with injuries, burns, fractures, as well as preoperative preparation.

Siberian Dry Live Vaccine Vaccine -Vaccinum Anthraxicum Vivum Siccum Sti.

Characteristic of the drug

Siberiaic dry live vaccine vehicle is dried under vacuum suspension of the vaccine strain STI-1. For its preparation, a resistant variant (mutant) of Siberian Bacilli, devoid of ability to cause disease in humans is used.

The name of the vaccine (STI) is given in honor of the Institute, where it was developed by N. N. Ginsburg and A. L. Tamarin. The dry-white dry vaccine is suspended in water without forming flakes or sediment.

Purpose, Indications and Contraindications

Siberiated live vaccine is designed to create active immunity against Siberian ulcers. Children between the ages of 14 and 16 are vaccinated against Siberian ulcers only in epidemic testimony and by decision of the Ministry of Health of the Federal Republic. Children under 14 vaccinations are not subject to. Revaccination is carried out annually at intervals one year according to the testimony.

Contraindications for vaccination against Siberian ulcers are:

acute infectious diseases or aggravation of chronic;

fevering condition;

diabetes;

heart disease in decompensation;

diseases accompanied by cachexia;

ulcerative disease of the stomach and duodenal intestine during the exacerbation period;

rheumatism during the period of exacerbation;

acute jade;

acute lesion and cirrhosis of the liver;

bronchial asthma, expressed lung emphysema;

thyroid disease (II-III degree);

lymphogranulomatosis;

skin diseases with extensive lesions of the skin surface;

malignant neoplasms.

"Care, nutrition and vaccine-prevention of a child", F.M.kitar

According to the need for carrying out all vaccinations are divided into planned (mandatory) and epidemiological indications. Planned vaccinations are carried out for the purposes of immunoprophylaxis of the most common or hazardous infectious diseases, mainly anthroponosis with the air-drip drive mechanism of pathogens, according to epidemiological indications - only in those places where it is necessary to ensure the immune layer of the population being risky, and when other measures ...

Specific prevention of infectious diseases plays a significant role in the system of anti-epidemic measurements. It is thanks to the widespread of the immunoprophylaxis that huge successes were achieved in the fight against many infectious diseases (diphtheria, poliomyelitis, cough, cortex, tetanus, etc.). Only in our country is about 170 million vaccinations per year. As a result, the incidence of many infections has declined sharply, up to liquidation ...

Persons to be vaccinated must be pre-examined by a doctor (Feldsher at the Feldsher-Okuscher or Feldsher Paragraph), taking into account anamnestic data. Persons who have contraindications listed in the instructions applied to the vaccine to the vaccines are not allowed constantly or temporarily. Children with chronic diseases, allergic conditions and others living in rural areas are instilled only after the doctor's advice. On the day vaccinations vaccinated also ...

In the room where vaccinations will be carried out, it is necessary to pre-wash the floors and furniture, it is desirable to use disinfectant solutions. Tool tables, couches for children are covered with strokes. Children can not be vaccinated in rooms where they take patients. The staff should work in pure bathrobes and caps (skins). The vaccinations are not allowed by health workers, which sufferers with minecraft skin diseases, angns, ...

Cholerogen-Antecisin - Cholero-Gen-Anatoxinum. The characteristic of the drug cholerogen-anatoxin is a purified and concentrated preparation obtained from a centrifuge of the bully culture of cholera vibrio strain 569V, neutralized by formalin. The drug is dry and liquid. Dry cholerogen-anatoxine has the form of a grayish-yellow porous mass, a liquid yellowish brown color with a small opalescence. Purpose, testimony and contraindications cholerogen-anatoxine is designed to create active artificial immunity against cholera ....